Supernus Pharmaceuticals CEO Jack Khattar's 2019 pay rises 13% to $8.1M
Supernus Pharmaceuticals reports 2019 executive compensation
By ExecPay News
Published: April 24, 2020
Supernus Pharmaceuticals reported fiscal year 2019 executive compensation information on April 24, 2020.
In 2019, five executives at Supernus Pharmaceuticals received on average a compensation package of $2.6M, a 26% increase compared to previous year.
Average pay of disclosed executives at Supernus Pharmaceuticals
Jack A. Khattar, Chief Executive Officer, received $8.1M in total, which increased by 13% compared to 2018. 82% of Khattar's compensation, or $6.6M, was in option awards. Khattar also received $594K in non-equity incentive plan, $812K in salary, as well as $80K in other compensation.
For fiscal year 2019, the median employee pay was $135,666 at Supernus Pharmaceuticals. Therefore, the ratio of Jack A. Khattar's pay to the median employee pay was 60 to one.
Stefan K.F. Schwabe, Chief Medical Officer, received a compensation package of $1.5M, which increased by 15% compared to previous year. 60% of the compensation package, or $885K, was in option awards.
Gregory S. Patrick, Chief Financial Officer, earned $1.4M in 2019, a 17% increase compared to previous year.
Padmanabh P. Bhatt, Chief Scientific Officer, received $1.3M in 2019, which increases by 7% compared to 2018.
Tami Martin, R.N., Senior Vice President, Regulatory Affairs, earned $875K in 2019, a 21% increase compared to previous year.
Related executives
Jack Khattar
Supernus Pharmaceuticals
Chief Executive Officer
Gregory Patrick
Supernus Pharmaceuticals
Chief Financial Officer
Padmanabh Bhatt
Supernus Pharmaceuticals
Chief Scientific Officer
Stefan Schwabe
Supernus Pharmaceuticals
Chief Medical Officer
Tami RN
Supernus Pharmaceuticals
Senior Vice President, Regulatory Affairs
You may also like
Source: SEC filing on April 24, 2020.